Protocol to evaluate a pilot program to upskill clinicians in providing genetic testing for familial melanoma

PLoS One. 2022 Dec 7;17(12):e0275926. doi: 10.1371/journal.pone.0275926. eCollection 2022.

Abstract

Introduction: Genetic testing for hereditary cancers can improve long-term health outcomes through identifying high-risk individuals and facilitating targeted prevention and screening/surveillance. The rising demand for genetic testing exceeds the clinical genetic workforce capacity. Therefore, non-genetic specialists need to be empowered to offer genetic testing. However, it is unknown whether patient outcomes differ depending on whether genetic testing is offered by a genetics specialist or a trained non-genetics clinician. This paper describes a protocol for upskilling non-genetics clinicians to provide genetic testing, randomise high-risk individuals to receive testing from a trained clinician or a genetic counsellor, and then determine whether patient outcomes differed depending on provider-type.

Methods: An experiential training program to upskill dermatologically-trained clinicians to offer genetic testing for familial melanoma is being piloted on 10-15 clinicians, prior to wider implementation. Training involves a workshop, comprised of a didactic learning presentation, case studies, simulated sessions, and provision of supporting documentation. Clinicians later observe a genetic counsellor led consultation before being observed leading a consultation. Both sessions are followed by debriefing with a genetic counsellor. Thereafter, clinicians independently offer genetic testing in the clinical trial. Individuals with a strong personal and/or family history of melanoma are recruited to a parallel-group trial and allocated to receive pre- and post- genetic testing consultation from a genetic counsellor, or a dermatologically-trained clinician. A mixed method approach measures psychosocial and behavioural outcomes. Longitudinal online surveys are administered at five timepoints from baseline to one year post-test disclosure. Semi-structured interviews with both patients and clinicians are qualitatively analysed.

Significance: This is the first program to upskill dermatologically-trained clinicians to provide genetic testing for familial melanoma. This protocol describes the first clinical trial to compare patient-reported outcomes of genetic testing based on provider type (genetic counsellors vs trained non-genetic clinicians).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disclosure*
  • Genetic Testing
  • Humans
  • Melanoma* / diagnosis
  • Melanoma* / genetics
  • Pilot Projects

Grants and funding

AML is funded by a National Health and Medical Research Council (NHMRC https://www.nhmrc.gov.au/) Early Career Fellowship (APP1158111). TY is funded by a NHMRC Investigator Grant (APP1194646). H. Peter Soyer holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127). Clare Primiero is supported by an Australian Government Research Training Program Scholarship (https://www.dese.gov.au/research-block-grants/research-training-program). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.